Quaterly Results | Kilitch Drugs (India) Ltd. | R Wadiwala Securities Pvt Ltd

KILITCH DRUGS (INDIA) LTD.

NSE : KILITCHBSE : 524500ISIN CODE : INE729D01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE337.101.7 (+0.51 %)
PREV CLOSE (Rs.) 335.40
OPEN PRICE (Rs.) 335.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 617
TODAY'S LOW / HIGH (Rs.)334.60 338.00
52 WK LOW / HIGH (Rs.)265.5 490
NSE337.052.05 (+0.61 %)
PREV CLOSE( Rs. ) 335.00
OPEN PRICE (Rs.) 336.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 337.05 (10)
VOLUME 4187
TODAY'S LOW / HIGH(Rs.) 332.75 338.75
52 WK LOW / HIGH (Rs.)293.53 500

Quarterly Results

Quarters
Select year
Particulars
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
489.24
431.40
612.26
561.66
Total Expenditure
438.84
398.76
466.32
474.31
PBIDT (Excl OI)
50.40
32.64
145.94
87.35
Other Income
66.60
25.57
16.98
17.25
Operating Profit
117.01
58.21
162.91
104.60
Interest
14.40
15.30
16.01
14.03
Exceptional Items
NA
NA
NA
NA
PBDT
102.61
42.91
146.90
90.57
Depreciation
8.63
8.43
8.47
8.07
Profit Before Tax
93.98
34.48
138.43
82.50
Tax
13.59
11.87
36.24
26.37
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
80.39
22.61
102.19
56.13
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
80.39
22.61
102.19
56.13
Minority Interest
1.50
7.63
1.81
3.46
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
81.90
30.26
103.99
59.61
Equity Capital
174.81
160.82
160.82
160.82
Face Value (IN RS)
10.00
10.00
10.00
10.00
Reserves
NA
NA
NA
NA
Calculated EPS
4.69
1.88
6.47
3.71
Calculated EPS (Annualised)
18.74
7.53
25.86
14.83
No of Public Share Holdings
6332609.00
4948146.00
4948146.00
4948146.00
% of Public Share Holdings
36.23
30.77
30.77
30.77
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
10.30
7.57
23.84
15.55
PBIDTM%
23.92
13.49
26.61
18.62
PBDTM%
20.97
9.95
23.99
16.13
PBTM%
19.21
7.99
22.61
14.69
PATM%
16.43
5.24
16.69
9.99
 
Notes
Notes
Notes
Notes